Commons Capital


Combinent BioMedical Systems

Combinent BioMedical Systems is an early-stage medical device company developing a transvaginal polymer drug delivery platform. This novel platform promises to greatly improve treatment of a number of women’s health diseases with large markets and high unmet needs, including those prevalent in the developing world. The company’s founders are Dr. Robert Langer, Professor of Chemical Engineering at MIT, and Dr. William Crowley, Chief of the Reproductive Endocrine Unit of the Department of Medicine at Massachusetts General Hospital.

Location: Cambridge, Massachusetts

Commons Capital’s co-investors include:
VIMAC Ventures and Cytyc Corporation (Nasdaq: CYTYC)


Healthcare Claros Diagnostics
  CodeRyte, Inc.
  Combinent BioMedical Systems
  HistoRx, Inc.
  Medical Metrix Solutions, Inc.
  Teladoc, Inc.
Energy CTP Hydrogen
  H2Gen Innovations
  Pelamis Wave Power Ltd.
  Protonex, Inc.
Education Apex Learning, Inc.
  OutStart Inc.
Environment Niman Ranch
  Passport Systems, Inc.
  Sun & Earth, Inc.
Other Solstice Capital II LP



  | Home | The Fund | Team | Portfolio | Global Health | News | Contact